- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/54 - Spiro-condensed
Patent holdings for IPC class C07D 209/54
Total number of patents in this class: 197
10-year publication summary
|
7
|
13
|
14
|
23
|
10
|
13
|
12
|
14
|
10
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Cropscience AG | 1967 |
16 |
| Bayer AG | 3404 |
15 |
| VALO Health, Inc. | 175 |
8 |
| KYORIN Pharmaceutical Co., Ltd. | 169 |
7 |
| F. Hoffmann-La Roche AG | 7932 |
6 |
| Takeda Pharmaceutical Company Limited | 2726 |
6 |
| KBP Biosciences Co., Ltd. | 29 |
6 |
| Bayer Intellectual Property GmbH | 2454 |
5 |
| Pfizer Inc. | 3405 |
4 |
| Syngenta Crop Protection AG | 6260 |
4 |
| Korea Advanced Institute of Science and Technology | 4473 |
4 |
| Institute for Basic Science | 363 |
4 |
| Merck Sharp & Dohme Corp. | 2189 |
3 |
| Cytokinetics, Inc. | 275 |
3 |
| Hong Kong Baptist University | 116 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 866 |
3 |
| Merck Sharp & Dohme LLC | 3735 |
3 |
| Glaxo Group Limited | 4154 |
2 |
| Bristol-myers Squibb Company | 4821 |
2 |
| Hoffmann-La Roche Inc. | 3548 |
2 |
| Other owners | 91 |